FDA’s tech overhaul is underway

Politico, January 14, 2020. The FDA is reviewing a handful of pain medications, including some new opioids, as the country continues to struggle with misuse and addiction to narcotics.

Read More »

Breast Implant Working Group’s Comments on FDA’s Draft Guidance to Improve Patient Communication on Breast Implants

December 23, 2019. We are urging that the FDA require a black box warning and Patient Informed Consent Check List that provides information about the risks of cancer, breast implant illness, and other serious health problems in explicit and easy-to-understand wording that all individuals considering breast implants can understand, regardless of educational level or stress that is inevitable when a person  is considering surgery.

Read More »